The Dylag Lab, led by Andrew M. Dylag, MD, FAAP, investigates the mechanisms by which early-life respiratory exposures, such as oxygen and mechanical ventilation, shape lung development and long-term respiratory outcomes in premature infants. The lab integrates bench, computational, and bedside research to improve lung health and reduce the severity of bronchopulmonary dysplasia (BPD).
Andrew M. Dylag, M.D.
Principal Investigator
- Sorted-Cell Proteomics Reveals an AT1-Associated Epithelial Cornification Phenotype and Suggests Endothelial Redox Imbalance in Human Bronchopulmonary Dysplasia.; American journal of physiology. Lung cellular and molecular physiology. 2025 Sep 17.
- The effectiveness of pulmonary hypertension screening in infants born preterm.; Early human development; Vol 209, pp. 106342. 2025 Jul 15.
- Less invasive surfactant administration in the delivery room: A quality improvement initiative.; Journal of perinatology : official journal of the California Perinatal Association. 2025 Jul 10.
- Machine Learning for Clinical Decision Support in the Neonatal Intensive Care Unit.; NeoReviews; Vol 26(6), pp. e372-e379. 2025 Jun 01.
Contact Us
Dylag Lab
601 Elmwood Avenue
Rochester, NY 14642